Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections.
about
Pathogenic Acinetobacter: from the Cell Surface to Infinity and BeyondCyclic di-GMP: the first 25 years of a universal bacterial second messengerAcinetobacter baumannii: evolution of a global pathogenImmunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis modelsAntibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogensVirstatin inhibits biofilm formation and motility of Acinetobacter baumannii.Lack of the PGA exopolysaccharide in Salmonella as an adaptive trait for survival in the host.Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinologyAcinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection.Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.Current advances and challenges in the development of Acinetobacter vaccines.Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in miceImmunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine CandidateAllosteric activation of exopolysaccharide synthesis through cyclic di-GMP-stimulated protein-protein interaction.Extended-spectrum antibodies protective against carbapenemase-producing EnterobacteriaceaeBordetella biofilms: a lifestyle leading to persistent infectionsStructural Basis for Translocation of a Biofilm-supporting Exopolysaccharide across the Bacterial Outer Membrane.Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.Acinetobacter baumannii Isolated from Lebanese Patients: Phenotypes and Genotypes of Resistance, Clonality, and Determinants of Pathogenicity.Efficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens.Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes.Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection.Adjuvant role of Pseudomonas flagellin for Acinetobacter baumannii biofilm associated protein.Nanoparticles for Control of Biofilms of Acinetobacter Species.The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAGImmunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumanniiUncovering the mechanisms of Acinetobacter baumannii virulence.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Q26771783-9D6EED41-9A86-40D5-AB86-5411B44480A1Q26850396-3E27C3D4-3513-49EF-93C9-BAF589F11BF0Q27008568-45E2662D-D1DE-4A24-BB2F-1276FDDA4404Q28539933-1DFF0273-5BDD-44FA-96BA-C9F089D75520Q30415823-09A976F7-328A-4958-AC51-C57899212E6CQ30577437-19A65507-CF48-42C0-B0D8-3BED8F02F8B9Q33778871-FAF04781-E089-4A2A-990D-03F1E0442251Q34653632-BA3681FC-49CD-44D3-B4F7-EE1060E2035CQ35887251-C1718DB4-6D59-453B-9B29-46005B96D5E4Q36052630-A98A5560-E0A7-4F00-A1C4-3B84126FAE59Q36198451-361E1919-BB55-4D66-B334-370EDCC54128Q36256352-10DFB50E-C742-4027-8B85-9B0C6719180AQ36277390-2E67EEE2-4F0E-4AEF-A436-C0B9653B3C60Q36391313-F06E488A-9D3D-4B61-8BE7-A26319C44EC2Q36555685-C1D4854B-36C1-4461-B0BA-760C7DD9E875Q36573679-9BA60682-40FF-4C05-ABDC-8041F688268DQ36595823-FCB23466-AEB7-4008-B655-918D650BC5BFQ36684178-033E20BE-F746-4156-9770-3941A3DBC330Q36794136-BED3BEAA-8F8D-40BE-8588-60FB382A3C9AQ36876141-5C800E21-B02A-4346-A753-2DCB9C3A4037Q37416593-4EA7F842-E01F-46E1-B15F-7D37E03F3774Q37438110-C9D30A17-449B-4C59-A262-7605B90B8F6AQ37561334-5C295E7C-2F66-406F-8B8A-86E85F8335C4Q37691079-E2D84888-A6BE-47A8-B818-44810EF06CBBQ38035276-2C638942-8F13-4055-9664-3F00713E3463Q38849929-F00FAF3F-B19E-47FE-9B1E-D0F74E893145Q40183459-708D5532-D377-49FB-9149-48FD8203D5ABQ40525045-BE378E0F-68D5-4CBA-86D9-022D05B6626CQ40674700-49B7C2D0-5659-49BB-9F5F-C16F0E4F791EQ40776497-DF78D60E-C508-4EF1-BD8E-E73D0162FEA4Q42367786-36F2A1C6-5E5A-4F98-AADC-E5242830A470Q46237978-38845FF9-AF4F-49E3-91EB-B308516E16B4Q53701548-D6C758A2-A1B2-4EA6-A614-88ABA87AA314
P2860
Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Poly-N-acetyl-β-(1-6)-glucosam ...... tobacter baumannii infections.
@ast
Poly-N-acetyl-β-(1-6)-glucosam ...... tobacter baumannii infections.
@en
type
label
Poly-N-acetyl-β-(1-6)-glucosam ...... tobacter baumannii infections.
@ast
Poly-N-acetyl-β-(1-6)-glucosam ...... tobacter baumannii infections.
@en
prefLabel
Poly-N-acetyl-β-(1-6)-glucosam ...... tobacter baumannii infections.
@ast
Poly-N-acetyl-β-(1-6)-glucosam ...... tobacter baumannii infections.
@en
P2093
P2860
P356
P1476
Poly-N-acetyl-β-(1-6)-glucosam ...... etobacter baumannii infections
@en
P2093
Cagla Bozkurt-Guzel
Jennifer M O'Malley
Leticia V Bentancor
Tomás Maira-Litrán
P2860
P304
P356
10.1128/IAI.05653-11
P407
P50
P577
2011-11-21T00:00:00Z